跳至主要内容
临床试验/NCT02845141
NCT02845141已完成不适用

Synthetic Bone Graft Substitute (Actifuse) vs. Autologous Spongiosa for Tunnel Enlargement in Revision Anterior Cruciate Ligament Reconstruction - a Histological and Radiological Assessment

Berufsgenossenschaftliche Unfallklinik Ludwigshafen2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2013年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40
试验地点
2
主要终点
histological assessment of bony consolidation

研究概览

简要总结

The overall objective is the histological and radiological assessment of bony consolidation of the tibial/femoral tunnel using either bone graft substitute (Actifuse) or autologous spongiosa in patients undergoing revision anterior cruciate ligament reconstruction.

Clinical correlation with the histological and radiological results using the SF36 questionnaire.

详细描述

* Study design: Monocentric, prospective, randomised study. Patients who need revision anterior cruciate ligament reconstruction and show a tunnel enlargement of >10mm will have a first operation filling the tibial/femoral tunnel either with bone graft substitute (Actifuse) or autologous spongiosa.

5 - 6 months after this first operation a CT will be performed to assess the bony consolidation of the former tibial/femoral tunnel. An MRI will be performed to assess vitality of the bone substitute.

An osseous biopsy will be taken from the tibial/femoral tunnel at the revision anterior cruciate ligament reconstruction approximately 6 months after bone grafting.

Clinical evaluation will be performed 6 weeks, 3 months and 6 months postoperative. At 6 months postoperative additional radiological evaluation and clinical assessment using the SF36 questionnaire will be performed.

  • Treatment: Either autologous spongiosa or Actifuse (MIS applicator) will be administered by the investigator as a bone graft substitute for tunnel enlargement in patients undergoing revision anterior cruciate ligament reconstruction.
  • Duration of Participation: The participation of each subject will be approximately 12 months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Patients in need of revision anterior cruciate ligament reconstruction

排除标准

  • Infection, wound healing complications

研究组 & 干预措施

Actifuse

Experimental

Actifuse to fill bone tunnel

干预措施: Actifuse (Procedure)

bone graft

Active Comparator

bone graft to fill bone tunnel

干预措施: bone graft (Procedure)

结局指标

主要结局

histological assessment of bony consolidation

时间窗: 6 months postop

histological probes during second intervention to measure bony ingrowth into bone substitute material

次要结局

  • IKDC Score(3, 6 and 12 Months)
  • stability measurement using KT1000(3, 6 and 12 Months)
  • SF36-Score(3, 6 and 12 Months)
  • Tegner Activity Score(3, 6 and 12 Months)

研究者

发起方
Berufsgenossenschaftliche Unfallklinik Ludwigshafen
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jan von Recum

Dr. med.

Berufsgenossenschaftliche Unfallklinik Ludwigshafen

研究点 (2)

Loading locations...

相似试验